 <h1>Narcan Nasal Spray Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>naloxone</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about naloxone. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Narcan Nasal Spray.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to naloxone: injection solution</i></p><p>Other dosage forms:</p><ul><li>nasal spray</li></ul><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, naloxone (the active ingredient contained in Narcan Nasal Spray) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking naloxone:</p><p>
<i>Incidence not known</i>
</p><ul>
<li>Abdominal or stomach cramps</li>
<li>body aches</li>
<li>convulsions</li>
<li>diarrhea</li>
<li>difficult or troubled breathing</li>
<li>excessive crying</li>
<li>fast, pounding, or irregular heartbeat or pulse</li>
<li>fever</li>
<li>goosebumps</li>
<li>increased or excessive unconscious or jerking movements</li>
<li>irregular, fast or slow, or shallow breathing</li>
<li>irritability</li>
<li>nausea or vomiting</li>
<li>nervousness</li>
<li>pale or blue lips, fingernails, or skin</li>
<li>restlessness</li>
<li>runny nose</li>
<li>shivering</li>
<li>sneezing</li>
<li>sweating</li>
<li>trembling</li>
<li>weakness</li>
<li>yawning</li>
</ul><p>
<div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to naloxone: compounding powder, injectable solution, nasal spray</i></p><h3>General</h3><p>This drug may precipitate abrupt opioid withdrawal in physically dependent persons; signs and symptoms may include body aches, fever, sweating, sneezing, yawning, nausea, vomiting, sweating, lacrimation, rhinorrhea, cramping, insomnia, chills/hot flashes, piloerection, tachycardia, anxiety, restlessness, irritability, tremulousness, hypertension, seizures, and cardiac arrest.  In the neonate, opioid withdrawal may also include convulsions, excessive crying, and hyperactive reflexes.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Tachycardia, hypotension, hypertension</p>
<p><b>Uncommon</b> (0.1% to 1%): Arrhythmia, bradycardia</p>
<p><b>Rare</b> (less than 0.1%): Fibrillation, cardiac arrest</p>
<p><b>Frequency not reported</b>: Left ventricular failure, flushing<sup>[Ref]</sup></p><p>In postoperative patients, many of whom had cardiovascular disease, the following cardiovascular side effects have been reported: hypotension, hypertension, atrial and ventricular tachycardia, ventricular fibrillation, left ventricular failure, and cardiac arrest.  Death, coma, and encephalopathy have been reported as sequelae of these events.<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Death, coma, and encephalopathy have been reported as a result of abrupt postoperative reversal of opioid depression, primarily in patients with preexisting cardiovascular disorders or in those who received other drugs with similar adverse cardiovascular effects.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Dizziness, headache</p>
<p><b>Uncommon</b> (0.1% to 1%): Tremor</p>
<p><b>Rare</b> (less than 0.1%): Seizures</p>
<p><b>Frequency not reported</b>: Coma, encephalopathy, convulsions, paraesthesia, grand mal convulsion<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very rare</b> (less than 0.01%): Pulmonary edema</p>
<p><b>Frequency not reported</b>: Dyspnea, respiratory depression, hypoxia, nasal dryness, nasal edema, nasal congestion, nasal inflammation<sup>[Ref]</sup></p><p>It has been suggested that pulmonary edema may be due to a centrally mediated massive catecholamine response leading to a dramatic shift of blood volume into the pulmonary vascular bed resulting in increased hydrostatic pressures.</p>
<p></p>
<p>Nasal dryness, nasal edema, nasal congestion, and nasal inflammation were the most common adverse reactions reported in clinical trials with naloxone nasal spray.<sup>[Ref]</sup></p><h3>Local</h3><p><b>Frequency not reported</b>: Nonspecific injection site reactions, irritation of vessel was after IV administration<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, vomiting</p>
<p><b>Uncommon</b> (0.1% to 1%): Diarrhea, dry mouth<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very rare</b> (less than 0.01%): Erythema multiforme</p>
<p><b>Frequency not reported</b>: Sweating<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Very rare</b> (less than 0.01%): Allergic reactions including urticaria, rhinitis, dyspnea, Quincke's edema, anaphylactic shock<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Frequency not reported</b>: Agitation, hallucination, tremulousness<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Musculoskeletal pain was one of the more commonly reported adverse reactions in clinical trials with naloxone (the active ingredient contained in Narcan Nasal Spray) nasal spray.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Musculoskeletal pain<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Narcan (naloxone)." DuPont Pharmaceuticals, Wilmington, DE. </p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>What are the different types of buprenorphine/naloxone?</li>
<li>What's the difference between naltrexone and naloxone?</li>
<li>How long does naloxone block opiates?</li>
<li>How does naloxone work in an overdose?</li>
<li>Does Sublocade have naloxone in it?</li>
<li>How do you administer naloxone?</li>
<li>Is this an addictive drug?</li>
<li>Will naloxone keep drug users from seeking treatment?</li>
<li>How do you administer Narcan Nasal Spray?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about Narcan Nasal Spray (naloxone)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>2 Reviews</li>
<li>FDA Alerts (2)</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Narcan nasal</li>
<li>Narcan &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li>Narcan Nasal &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Evzio</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Opioid Overdose</li>
<li>Reversal of Opioid Sedation</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to naloxone: compounding powder, injectable solution, nasal spray</i></p><h3>General</h3><p>This drug may precipitate abrupt opioid withdrawal in physically dependent persons; signs and symptoms may include body aches, fever, sweating, sneezing, yawning, nausea, vomiting, sweating, lacrimation, rhinorrhea, cramping, insomnia, chills/hot flashes, piloerection, tachycardia, anxiety, restlessness, irritability, tremulousness, hypertension, seizures, and cardiac arrest.  In the neonate, opioid withdrawal may also include convulsions, excessive crying, and hyperactive reflexes.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Tachycardia, hypotension, hypertension</p><p><b>Uncommon</b> (0.1% to 1%): Arrhythmia, bradycardia</p><p><b>Rare</b> (less than 0.1%): Fibrillation, cardiac arrest</p><p><b>Frequency not reported</b>: Left ventricular failure, flushing<sup>[Ref]</sup></p><p>In postoperative patients, many of whom had cardiovascular disease, the following cardiovascular side effects have been reported: hypotension, hypertension, atrial and ventricular tachycardia, ventricular fibrillation, left ventricular failure, and cardiac arrest.  Death, coma, and encephalopathy have been reported as sequelae of these events.<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Death, coma, and encephalopathy have been reported as a result of abrupt postoperative reversal of opioid depression, primarily in patients with preexisting cardiovascular disorders or in those who received other drugs with similar adverse cardiovascular effects.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Dizziness, headache</p><p><b>Uncommon</b> (0.1% to 1%): Tremor</p><p><b>Rare</b> (less than 0.1%): Seizures</p><p><b>Frequency not reported</b>: Coma, encephalopathy, convulsions, paraesthesia, grand mal convulsion<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very rare</b> (less than 0.01%): Pulmonary edema</p><p><b>Frequency not reported</b>: Dyspnea, respiratory depression, hypoxia, nasal dryness, nasal edema, nasal congestion, nasal inflammation<sup>[Ref]</sup></p><p>It has been suggested that pulmonary edema may be due to a centrally mediated massive catecholamine response leading to a dramatic shift of blood volume into the pulmonary vascular bed resulting in increased hydrostatic pressures.</p><p></p><p>Nasal dryness, nasal edema, nasal congestion, and nasal inflammation were the most common adverse reactions reported in clinical trials with naloxone nasal spray.<sup>[Ref]</sup></p><h3>Local</h3><p><b>Frequency not reported</b>: Nonspecific injection site reactions, irritation of vessel was after IV administration<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, vomiting</p><p><b>Uncommon</b> (0.1% to 1%): Diarrhea, dry mouth<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very rare</b> (less than 0.01%): Erythema multiforme</p><p><b>Frequency not reported</b>: Sweating<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Very rare</b> (less than 0.01%): Allergic reactions including urticaria, rhinitis, dyspnea, Quincke's edema, anaphylactic shock<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Frequency not reported</b>: Agitation, hallucination, tremulousness<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Musculoskeletal pain was one of the more commonly reported adverse reactions in clinical trials with naloxone (the active ingredient contained in Narcan Nasal Spray) nasal spray.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Musculoskeletal pain<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Narcan (naloxone)." DuPont Pharmaceuticals, Wilmington, DE. </p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>What are the different types of buprenorphine/naloxone?</li>
<li>What's the difference between naltrexone and naloxone?</li>
<li>How long does naloxone block opiates?</li>
<li>How does naloxone work in an overdose?</li>
<li>Does Sublocade have naloxone in it?</li>
<li>How do you administer naloxone?</li>
<li>Is this an addictive drug?</li>
<li>Will naloxone keep drug users from seeking treatment?</li>
<li>How do you administer Narcan Nasal Spray?</li>
</ul><h2>More about Narcan Nasal Spray (naloxone)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>2 Reviews</li>
<li>FDA Alerts (2)</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Narcan nasal</li>
<li>Narcan &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li>Narcan Nasal &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Opioid Overdose</li>
<li>Reversal of Opioid Sedation</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>